Drug Profile
Research programme: hepatitis therapy - AlphaRx
Alternative Names: ARX-1088Latest Information Update: 23 Sep 2011
Price :
$50
*
At a glance
- Originator AlphaRx
- Class
- Mechanism of Action Interferon modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral hepatitis
Most Recent Events
- 05 Jul 2011 Discontinued - Preclinical for Viral hepatitis in China (PO)
- 18 Dec 2009 Preclinical trials in Viral hepatitis in China (PO)